Skip to main content

Peer Review reports

From: Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality

Original Submission
22 Jun 2022 Submitted Original manuscript
25 Jul 2022 Reviewed Reviewer Report
11 Aug 2022 Reviewed Reviewer Report
13 Sep 2022 Reviewed Reviewer Report
14 Dec 2022 Reviewed Reviewer Report
21 Mar 2023 Author responded Author comments - Dong-Jing Fu
Resubmission - Version 2
21 Mar 2023 Submitted Manuscript version 2
18 Apr 2023 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
10 Jul 2023 Editorially accepted
11 Aug 2023 Article published 10.1186/s12888-023-05017-y

You can find further information about peer review here.

Back to article page